Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Kelly E. Fathers"'
Autor:
Christine Brezden‐Masley, Kelly E. Fathers, Megan E. Coombes, Behin Pourmirza, Cloris Xue, Katarzyna J. Jerzak
Publikováno v:
Cancer Medicine, Vol 9, Iss 20, Pp 7548-7557 (2020)
Abstract Background There have been few publications exploring the characteristics, treatment pathways, and health‐care costs by stage in patients with a triple‐negative breast cancer (TNBC) phenotype. Methods Data from a publicly funded health
Externí odkaz:
https://doaj.org/article/eff8ed568b694575980691e31bf11aec
Autor:
David R. Kaplan, Meredith S. Irwin, Cynthia E. Hawkins, Lynn Kee, Samar Mouaaz, Lincoln D. Stein, Christina K. Yung, Robin Hallett, Kelly E. Fathers, Bo Kyung A. Seong
Metastatic relapse is the major cause of death in pediatric neuroblastoma, where there remains a lack of therapies to target this stage of disease. To understand the molecular mechanisms mediating neuroblastoma metastasis, we developed a mouse model
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ee57c53564def9917ee6fb51d72a21f
https://doi.org/10.1158/0008-5472.c.6509016.v1
https://doi.org/10.1158/0008-5472.c.6509016.v1
Autor:
David R. Kaplan, Meredith S. Irwin, Cynthia E. Hawkins, Lynn Kee, Samar Mouaaz, Lincoln D. Stein, Christina K. Yung, Robin Hallett, Kelly E. Fathers, Bo Kyung A. Seong
Further details of materials & methods provided in supplementary data.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::413784f8d6dec04f4d29506eb5d789e5
https://doi.org/10.1158/0008-5472.22414536
https://doi.org/10.1158/0008-5472.22414536
Autor:
David R. Kaplan, Meredith S. Irwin, Cynthia E. Hawkins, Lynn Kee, Samar Mouaaz, Lincoln D. Stein, Christina K. Yung, Robin Hallett, Kelly E. Fathers, Bo Kyung A. Seong
Legends for Supplementary figures are provided
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::261542dd37447e35c181f49df15a60e9
https://doi.org/10.1158/0008-5472.22414542.v1
https://doi.org/10.1158/0008-5472.22414542.v1
Autor:
David R. Kaplan, Meredith S. Irwin, Cynthia E. Hawkins, Lynn Kee, Samar Mouaaz, Lincoln D. Stein, Christina K. Yung, Robin Hallett, Kelly E. Fathers, Bo Kyung A. Seong
Supplementary Figure 1 - The metastatic subpopulations display enhanced metastatic burden relative to the SK-N-AS-TR parental cell line in vivo and increased chemoresistance in vitro. Supplementary Figure 2 - GSEA enrichment map show signaling pathwa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac0029b54dba442ad7595f8d2dc83024
https://doi.org/10.1158/0008-5472.22414539.v1
https://doi.org/10.1158/0008-5472.22414539.v1
Autor:
David R. Kaplan, Meredith S. Irwin, Cynthia E. Hawkins, Lynn Kee, Samar Mouaaz, Lincoln D. Stein, Christina K. Yung, Robin Hallett, Kelly E. Fathers, Bo Kyung A. Seong
Supplementary Table 1 - Summary of metastatic lesions in mice injected with the parental and enhanced metastatic subpopulations of SK-N-AS-TR.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6db66261b933412ef4220ae9d243e2cc
https://doi.org/10.1158/0008-5472.22414533.v1
https://doi.org/10.1158/0008-5472.22414533.v1
Autor:
Cloris Xue, Megan E. Coombes, Katarzyna J. Jerzak, Behin Pourmirza, Kelly E Fathers, Christine Brezden-Masley
Publikováno v:
Breast Cancer Research and Treatment
Purpose We sought to expand the currently limited, Canadian, population-based data on the characteristics, treatment pathways, and health care costs according to stage in patients with human epidermal growth factor receptor-2 positive (HER2+) breast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::501bd46c2f89be59c7f1faf32d3d7c13
http://europepmc.org/articles/PMC7921035
http://europepmc.org/articles/PMC7921035
Autor:
Behin Pourmirza, Cloris Xue, Christine Brezden-Masley, Megan E. Coombes, Katarzyna J. Jerzak, Kelly E Fathers
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 9, Iss 20, Pp 7548-7557 (2020)
Cancer Medicine, Vol 9, Iss 20, Pp 7548-7557 (2020)
Background There have been few publications exploring the characteristics, treatment pathways, and health‐care costs by stage in patients with a triple‐negative breast cancer (TNBC) phenotype. Methods Data from a publicly funded health‐care sys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d6b352c6566c03d1b812015c1896f06
https://doi.org/10.1002/cam4.3038
https://doi.org/10.1002/cam4.3038
Autor:
Kelly E Fathers, Christine Brezden-Masley, Megan E. Coombes, Behin Pourmirza, Katarzyna J. Jerzak, Cloris Xue
Publikováno v:
Cancer Research. 80:P2-08
Background: Since the discovery of HER2-targeted treatments for HER2+ breast cancer (BC), women with this historically poor-prognosis subtype have benefitted from dramatic improvements in outcome. As treatment algorithms and staging become more perso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22d5494e8a2980c9184a1ab78a8a6dc7
https://doi.org/10.1158/1538-7445.sabcs19-p2-08-23
https://doi.org/10.1158/1538-7445.sabcs19-p2-08-23
Autor:
Kelly E Fathers, Megan E. Coombes, Katarzyna J. Jerzak, Behin Pourmirza, Cloris Xue, Christine Brezden-Masley
Publikováno v:
Breast Cancer Research and Treatment
Purpose To update and expand on data related to treatment, resource utilization, and costs by cancer stage in Canadian patients with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2−) breast cancer (BC). Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e68258318f45643b512b0fead7c04aa
https://pubmed.ncbi.nlm.nih.gov/33064230
https://pubmed.ncbi.nlm.nih.gov/33064230